Perspective
Insurer Formularies Complicate the Adoption of Biosimilar Cancer Therapies
April 8, 2021
Featured Experts: Alice Chen, PhD, Karen Van Nuys, PhD
Perspective
April 8, 2021
Featured Experts: Alice Chen, PhD, Karen Van Nuys, PhD
News
April 7, 2021
Featured Experts: Neeraj Sood, PhD
Journal Article
April 6, 2021
Featured Experts: Wändi Bruine de Bruin, MSc, PhD
April 4, 2021
White Paper
March 31, 2021
Featured Experts: Paul Ginsburg, PhD
Evidence Base
March 31, 2021
Featured Experts: Dima M. Qato, PharmD, MPH, PhD
March 26, 2021
Perspective
March 26, 2021
Featured Experts: Erin Trish, PhD
Journal Article
March 23, 2021
Featured Experts: Erin Trish, PhD, Eugene Lin, MD, MS
News
March 23, 2021
Featured Experts: Erin Trish, PhD, Eugene Lin, MD, MS
Journal Article
March 18, 2021
Featured Experts: Emma Aguila, PhD
News
March 17, 2021
Featured Experts: Darius Lakdawalla, PhD, Karen Van Nuys, PhD
White Paper
March 17, 2021
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD, Karen Van Nuys, PhD
Journal Article
March 17, 2021
Featured Experts: Neeraj Sood, PhD
Journal Article
March 17, 2021
Featured Experts: Sarah Axeen, PhD, Michael Menchine, MD, MPH, Sophie Terp, MD, MPH
Journal Article
March 16, 2021
Featured Experts: Jakub Hlávka, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD
Evidence Base
March 15, 2021